Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Librero, Julián ^a,b   Sanfélix Gimeno, Gabriel ^a,b   Peiró, Salvador ^a,b  

^a Center for Research in Public Health (CSISP)   (Spain)

^b Research Network on Health Services in Chronic Diseases   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTROPY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY; SPAIN; ANGINA PECTORIS; CORONARY DISEASE; DOCTOR PATIENT RELATION; HOSPITAL DISCHARGE; MIDDLE AGED; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; CORONARY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT DISCHARGE; PHYSICIAN-PATIENT RELATIONS; PLATELET AGGREGATION INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPAIN;

EID: 84984601479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161381     Document Type: Article

References (39)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-97. PMID: 16079372
2. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557):15. PMID: 16790458
3. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011; 30(1):91-9.
4. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008; 155(4):772-9. doi: 10.1016/j.ahj.2007.12.011 PMID: 18371492
5. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005; 58(4):323-37. PMID: 15862718
6. Crystal S, Akincigil A, Bilder S, Walkup JT. Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies. Med Care. 2007; 45(10 Supl 2):S58-65. PMID: 17909385
7. Franklin JM, Shrank WH, Pakes J, Sanfélix-Gimeno G, Matlin OS, Brennan TA, et al. Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care. 2013; 51(9):789-96. PMID: 23685406
8. Muthén B, Muthén LK. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000; 24(6):882-91. PMID: 10888079
9. Nagin DS, Odgers CL. Group-based trajectory modelling in clinical research. Annu Rev Clin Psychol. 2010; 6:109-38. doi: 10.1146/annurev.clinpsy.121208.131413 PMID: 20192788
10. Bogner HR, Lin JY, Morales KH. Patterns of early adherence to the antidepressant citalopram among older primary care patients: the prospect study. Int J Psychiatry Med. 2006; 36(1):103-19. PMID: 16927582
11. Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, et al Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol. 2010; 35(9):1028-37. doi: 10.1093/jpepsy/jsq015 PMID: 20304772
12. Riegel B. Predictors of objectively measured medication nonadherence in adults with heart failure. Circ Heart Fail. 2011; 5:430-436.
13. Bastard M, Fall MB, Lanièce I, Taverne B, Desclaux A, Ecochard R, et al. Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis. J Acquir Immune Defic Syndr. 2011; 57(1):55-61. PMID: 21775934
14. Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA. 2011; 305(16):1669-76. doi: 10.1001/jama.2011.506 PMID: 21521848
15. Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, et al. Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis. Clinicoecon Outcomes Res 2014; 6:197-208. doi: 10.2147/CEOR.S59339 PMID: 24748809
16. Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up. Ophthalmology 2015. doi: 10.1016/j.ophtha.2015.06.039
17. Chen HY, Saczynski JS, Lapane KL, Kiefe CI, Goldberg RJ. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review. Heart Lung. 2015 Jul-Aug; 44(4):299-308. doi: 10.1016/j.hrtlng.2015.02.004 PMID: 25766041
18. Sanfélix-Gimeno G, Peiró S, Ferreros I, Pérez-Vicente R, Librero J, Catalá-López F, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm. 2013; 19(3):247-57. PMID: 23537459
19. Sanfélix-Gimeno G, Franklin JM, Shrank WH, Carlo M, Tong AY, Reisman L, et al. Did HEDIS get it right? Evaluating the quality of a quality measure: adherence to β-blockers and cardiovascular outcomes after myocardial infarction. Med Care. 2014Jul; 52(7):669-76. PMID: 24926716
20. Nagin DS. Analyzing developmental trajectories. A semi-parametric group based approach. Psychological Methods. 1999; 6:18-34.
21. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978; 6:461-464.
22. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974; 19:716-723.
23. Lo Y, Mendell N, Rubin D. Testing the number of components in a normal mixture. Biometrika. 2001; 88 (3): 767-778.
24. Muthén LK, Muthén BO. Mplus User's Guide (1998-2007). 5th Ed. Los Angeles CA: Muthén & Muthén; 2007. Avalaible in: http://people.oregonstate.edu/~acock/growth/Mplus%20files/Documentation/Mplus%20User's%20Guide%20to%205.0.pdf; Accesed: 2013, November 21.
25. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012. Avalaible in: ; Accesed: 2013, November 21.
26. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010; 48(3):196-202. PMID: 19890219
27. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009; 2(5):451-7. doi: 10.1161/CIRCOUTCOMES.108.841635 PMID: 20031876
28. Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013; 126(4):357.e7-357.e27.
29. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50:105-16. PMID: 9048695
30. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006; 44(5):471-77. PMID: 16641666
31. Twisk J, Hoekstra T. Classifying developmental trajectories over time should be done with great caution: a comparison between methods. J Clin Epidemiol. 2012; 65:1078-1087. doi: 10.1016/j.jclinepi.2012.04.010 PMID: 22818946
32. Hoekstra T. Applied latent class models for epidemiology (PhD Thesis). Amsterdan: Vrije Universiteit Amsterdam; 2013. Avalaible in: http://www.ubvu.vu.nl/pub/?lang=-nl&PublicationType=&objectid=109&objecttype=page&SearchObjectid=9&st5=0&st6=0&mode=Basic&tab=all&indx=1&dum=true&srt=rank&vid=VU-V1&frbg=&vl%28freeText0%29=hoekstra&trefwoord=hoekstra; Accesed 2013, November 21.
33. Bauer DJ, Curran PJ. Distributional assumptions of growth mixture models: Implications for overextraction of latent trajectory classes. Psychol Methods. 2003; 8:338-63. PMID: 14596495
34. Bauer DJ. Observations on the use of growth mixture models in psychological research. Multivariate Behavioural Res. 2007; 42:757-68.
35. Hoeksma JB, Kelderman H. On growth curves and mixture models. Infant Child Develop. 2006; 15:627-34.
36. Stanger C. Latent growth mixture models: An important new tool for developmental researchers. Infant Child Develop. 2006; 15:635-7.
37. Nylund K, Asparouhov T, Muthén B. Deciding on the number of classes in Latent Class Analysis and growth Mixture Modelling: A Monte carlo Simulation Study. Structural Equation Modelling. 2007; 14:535-69.
38. Bauer DJ, Curran PJ. The integration of continuous and discrete latent variable models: potential problems and promising opportunities. Psychol Methods. 2004; 9:3-29. PMID: 15053717
39. Bauer DJ, Curran PJ. Overextraction of latent trajectory classes: Much ado about nothing? Reply to Rindskopf (2003), Muthén (2003), and Cudeck and Henly (2003). Psychol Methods. 2003; 8:384-93.